{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:06:54Z","timestamp":1789729614435,"version":"4.0.1"},"reference-count":74,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016382","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:55:46Z","timestamp":1789728946000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Service delivery interventions for lipid testing and lipid-lowering therapy for primary and secondary prevention of cardiovascular disease in adults"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0493-9790","authenticated-orcid":false,"given":"Ana-Mihaela","family":"Zorger","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalena","family":"Muth","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Shokraee","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty; Heinrich Heine University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siavosh","family":"Olfati","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Monsef","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan VA","family":"Franco","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK D\u00fcsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty; Heinrich Heine University D\u00fcsseldorf; D\u00fcsseldorf Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Skoetz","sequence":"additional","affiliation":[{"name":"Cochrane Evidence Synthesis Unit Germany\/UK, Institute of Public Health; Faculty of Medicine and University Hospital Cologne, University of Cologne; Cologne Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"10.1002\/14651858.CD016382-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023","volume":"86","author":"Stark","year":"2025","journal-title":"JACC"},{"key":"10.1002\/14651858.CD016382-BIB0002|cit2","unstructured":"World Health Organization Cardiovascular diseases (CVDs) https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)"},{"issue":"1","key":"10.1002\/14651858.CD016382-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-015-0255-y","article-title":"Atherosclerotic cardiovascular disease: a review of initiators and protective factors","volume":"24","author":"Ellulu","year":"2016","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD016382-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1016\/s2214-109x(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","author":"Kaptoge","year":"2019","journal-title":"Lancet Global Health"},{"key":"10.1002\/14651858.CD016382-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 focused update of the 2019 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD016382-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X16999201210200342","article-title":"Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review","volume":"17","author":"Alloubani","year":"2021","journal-title":"Current Cardiology Reviews"},{"key":"10.1002\/14651858.CD016382-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.cjca.2024.04.017","article-title":"Dyslipidemia and the current state of cardiovascular disease: epidemiology, risk factors, and effect of lipid lowering","volume":"40","author":"Brunham","year":"2024","journal-title":"Canadian Journal of Cardiology"},{"issue":"9438","key":"10.1002\/14651858.CD016382-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/s0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"10226","key":"10.1002\/14651858.CD016382-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/s0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD016382-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"e0002905","DOI":"10.1371\/journal.pgph.0002905","article-title":"Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries","volume":"4","author":"Li","year":"2024","journal-title":"PLOS Global Public Health"},{"issue":"-","key":"10.1002\/14651858.CD016382-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.3399\/bjgp12X630241","article-title":"Point-of-care testing for the analysis of lipid panels: primary care diagnostic technology update","volume":"62","author":"Pl\u00fcddemann","year":"2012","journal-title":"British Journal of General Practice"},{"key":"10.1002\/14651858.CD016382-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1136\/bmj.322.7297.1285","article-title":"Point of care testing","volume":"322","author":"Price","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016382-BIB0013|cit13","unstructured":"Afinion Lipid Panel https:\/\/www.globalpointofcare.abbott\/de\/de\/product-details\/afinion-lipid-panel.html"},{"key":"10.1002\/14651858.CD016382-BIB0014|cit14","unstructured":"CardioChek Plus https:\/\/www.ptsdiagnostics.com\/cardiochek-plus-analyzer\/"},{"key":"10.1002\/14651858.CD016382-BIB0015|cit15","unstructured":"Cholestech LDX analyzer https:\/\/www.globalpointofcare.abbott\/ww\/en\/product-details\/cholestech-ldx-system.html"},{"key":"10.1002\/14651858.CD016382-BIB0016|cit16","unstructured":"PocDoc Lipid Test https:\/\/pocdoc.co\/articles\/understanding-pocdoc-lipid-test-results"},{"issue":"4","key":"10.1002\/14651858.CD016382-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"e0174504","DOI":"10.1371\/journal.pone.0174504","article-title":"The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: a cluster randomised controlled trial and qualitative investigation","volume":"12","author":"Wells","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD016382-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pmedr.2017.05.016","article-title":"Point-of-care testing to promote cardiovascular disease risk assessment: a proof of concept study","volume":"7","author":"Karmali","year":"2017","journal-title":"Preventive Medicine Reports"},{"key":"10.1002\/14651858.CD016382-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.2147\/PPA.S542881","article-title":"Pharmacist-led Interventions to improve medication adherence among patients with multimorbidity: a scoping review","volume":"19","author":"Sholihah","year":"2025","journal-title":"Patient Preference and Adherence"},{"issue":"3","key":"10.1002\/14651858.CD016382-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/17151635231164989","article-title":"Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists","volume":"156","author":"Babadagli","year":"2023","journal-title":"Canadian Pharmacists Journal"},{"issue":"3","key":"10.1002\/14651858.CD016382-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"e080726","DOI":"10.1136\/bmjopen-2023-080726","article-title":"Can we trust published evidence on point-of-care tests for cholesterol? A rapid review","volume":"15","author":"Mutepfa","year":"2025","journal-title":"BMJ Open"},{"issue":"17","key":"10.1002\/14651858.CD016382-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"13288","DOI":"10.3390\/ijms241713288","article-title":"Advances in treatment of dyslipidemia","volume":"24","author":"Dybiec","year":"2023","journal-title":"International Journal of Molecular Science"},{"key":"10.1002\/14651858.CD016382-BIB0023|cit23","unstructured":"NHS England Summary of national guidance for lipid management https:\/\/www.england.nhs.uk\/aac\/publication\/summary-of-national-guidance-for-lipid-management\/ https:\/\/www.england.nhs.uk\/aac\/publication\/summary-of-national-guidance-for-lipid-management\/"},{"issue":"25","key":"10.1002\/14651858.CD016382-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1002\/14651858.CD016382-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jacl.2025.05.002","article-title":"Multidisciplinary teams in clinical lipidology and cardiometabolic care: a National Lipid Association expert clinical review","volume":"19","author":"Cheeley","year":"2025","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016382-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.jacc.2025.06.013","article-title":"2025 ACC\/AHA clinical practice guidelines core principles and development process: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"25","author":"Otto","year":"2025","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD016382-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/clc.23935","article-title":"Nonadherence to lipid-lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease","volume":"46","author":"Desai","year":"2023","journal-title":"Clinical Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD016382-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"e1003841","DOI":"10.1371\/journal.pmed.1003841","article-title":"Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: a cross-sectional study of nationally representative surveys","volume":"18","author":"Marcus","year":"2021","journal-title":"PLoS Medicine"},{"issue":"9","key":"10.1002\/14651858.CD016382-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"e073125","DOI":"10.1136\/bmjopen-2023-073125","article-title":"Exploring barriers and facilitators of primary care physicians towards optimising statin therapy in patients with hyperlipidaemia in the very high-risk group: a qualitative study in Singapore","volume":"13","author":"Beh","year":"2023","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD016382-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.7958","article-title":"Measuring public preferences for statin therapy using the smallest worthwhile difference","volume":"-","author":"Luo","year":"2026","journal-title":"JAMA Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD016382-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cjco.2020.07.002","article-title":"Barriers and facilitators to using statins: a qualitative study with patients and family physicians","volume":"2","author":"Butalia","year":"2020","journal-title":"CJC Open"},{"issue":"3","key":"10.1002\/14651858.CD016382-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11845-025-03973-w","article-title":"Low awareness of lipid disorders amongst individuals despite their high prevalence","volume":"194","author":"Walsh","year":"2025","journal-title":"Irish Journal of Medical Science"},{"issue":"1","key":"10.1002\/14651858.CD016382-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1506","article-title":"Global guidance for dyslipidaemia management in adults: a scoping review","volume":"20","author":"Moran","year":"2025","journal-title":"Global Heart"},{"issue":"3","key":"10.1002\/14651858.CD016382-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/j.1875-9114.2012.01022.x","article-title":"A systematic review of the evidence for pharmacist care of patients with dyslipidemia","volume":"32","author":"Charrois","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1002\/14651858.CD016382-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1345\/aph.1K618","article-title":"Sensitivity of patient outcomes to pharmacist interventions. Part III: systematic review and meta-analysis in hyperlipidemia management","volume":"42","author":"Machado","year":"2008","journal-title":"Annals of Pharmacotherapy"},{"issue":"2","key":"10.1002\/14651858.CD016382-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"823\u201334","DOI":"10.1016\/j.atherosclerosis.2007.01.023","article-title":"Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials","volume":"196","author":"Chan","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD016382-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2017.08.014","article-title":"Effects of age, gender and statin dose on lipid levels: results from the VOYAGER meta-analysis database","volume":"265","author":"Karlson","year":"2017","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1002\/14651858.CD016382-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.jacl.2023.03.008","article-title":"Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemia","volume":"17","author":"Paquette","year":"2023","journal-title":"Journal of Clinical Lipidology"},{"issue":"4","key":"10.1002\/14651858.CD016382-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2217\/clp.11.25","article-title":"Management of dyslipidemia in HIV-infected patients","volume":"6","author":"Sugden","year":"2011","journal-title":"Journal of Clinical Lipidology"},{"issue":"7","key":"10.1002\/14651858.CD016382-BIB0040|cit40","doi-asserted-by":"publisher","DOI":"10.3390\/ph17070913","article-title":"Lipoprotein metabolism, dyslipidemia, and lipid-lowering therapy in women: a comprehensive review","volume":"17","author":"Zimodro","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1002\/14651858.CD016382-BIB0041|cit41","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0042|cit42","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD016382-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016382-BIB0044|cit44","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0045|cit45","unstructured":"Reeves BC Deeks JJ Higgins JP Shea B Tugwell P Wells GA Chapter 24: Including non-randomized studies on intervention effects (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0046|cit46","unstructured":"Lindson N Hartmann-Boyce J Bero L Dumville J Flemyng E Livingstone N Defining and determining which quantitative study designs to include in your systematic review of effects of a healthcare intervention. Version 1.2. Cochrane, 2024 https:\/\/methods.cochrane.org\/defining-and-determining-which-quantitative-study-designs-include-your-systematic-review-effects"},{"issue":"2","key":"10.1002\/14651858.CD016382-BIB0047|cit47","first-page":"131","article-title":"POCT accreditation ISO 15189 and ISO 22870: making the point","volume":"32","author":"Oliver","year":"2021","journal-title":"Journal of the International Federation of Clinical Chemistry and Laboratory Medicine"},{"key":"10.1002\/14651858.CD016382-BIB0048|cit48","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies (chapter last updated March 2025). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1. Cochrane, 2025 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/hir.12269","article-title":"Translating the Cochrane EMBASE RCT filter from the Ovid interface to Embase.com: a case study","volume":"36","author":"Glanville","year":"2019","journal-title":"Health Information and Libraries Journal"},{"issue":"5","key":"10.1002\/14651858.CD016382-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/jrsm.1425","article-title":"Development and validation of study filters for identifying controlled non-randomized studies in PubMed and Ovid MEDLINE","volume":"11","author":"Waffenschmidt","year":"2020","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD016382-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jclinepi.2016.01.021","article-title":"PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement","volume":"75","author":"McGowan","year":"2016","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016382-BIB0052|cit52","unstructured":"Cumpston M Lasserson T Flemyng E Page MJ Chapter III: Reporting the review (chapter last updaed August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jclinepi.2021.01.006","article-title":"An evaluation of Cochrane Crowd found that crowdsourcing produced accurate results in identifying randomized trials","volume":"133","author":"Noel-Storr","year":"2021","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016382-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jclinepi.2020.11.003","article-title":"Machine learning reduces workload with minimal risk of missing studies: development and evaluation of an RCT classifier for Cochrane reviews","volume":"133","author":"Thomas","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016382-BIB0055|cit55","unstructured":"Covidence Veritas Health Innovation"},{"key":"10.1002\/14651858.CD016382-BIB0056|cit56","unstructured":"Claude 4.6 Sonnet [Large language model]. https:\/\/claude.ai\/ Anthropic 2026"},{"key":"10.1002\/14651858.CD016382-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016382-BIB0058|cit58","unstructured":"Sterne J Mathur MB Elbers RG Hr\u00f3bjartsson A McAleenan A Reeves B The Risk Of Bias In Non-randomized Studies \u2013 of Interventions, Version 2 (ROBINS-I V2) assessment tool https:\/\/drive.google.com\/file\/d\/1tXCLVa7aFVaiV3OnitZDgAnX3kXWXor0\/view"},{"key":"10.1002\/14651858.CD016382-BIB0059|cit59","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0060|cit60","unstructured":"Eldridge S Campbell M Campbell MJ Drahota AK Giradeau B Reeves BC Revised Cochrane risk of bias tool for randomized trials (RoB 2) Additional considerations for cluster-randomized trials (RoB 2 CRT) https:\/\/drive.google.com\/file\/d\/1yDQtDkrp68_8kJiIUdbongK99sx7RFI-\/view"},{"key":"10.1002\/14651858.CD016382-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD016382-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD016382-BIB0063|cit63","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0064|cit64","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis (chapter last updated August 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0065|cit65","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD016382-BIB0066|cit66","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (chapter last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0067|cit67","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"368:l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"16","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016382-BIB0069|cit69","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2026"},{"key":"10.1002\/14651858.CD016382-BIB0070|cit70","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0071|cit71","unstructured":"Sterne JA Hern\u00e1n MA McAleenan A Reeves BC Higgins JP Chapter 25: Assessing risk of bias in a non-randomized study (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0072|cit72","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016382-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD016382-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:56:08Z","timestamp":1789728968000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016382"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":74,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016382","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}